Barbiturates LP14546-3
LOINC Hierarchy
Select the title to see children of the section (▸) or the LOINC code. Select a code to view information about the section/code.
▸ Allobarbital LP18129-4
▸ Barbiturates | Blood | Drug toxicology LP390626-2
▸ Barbiturates | Body fluid | Drug toxicology LP390627-0
▸ Allyl-sec-butyl-barbiturate LP18124-5
▸ Amobarbital LP15163-6
▸ Barbiturates | Gastric fluid | Drug toxicology LP390628-8
▸ Barbiturates | Hair | Drug toxicology LP390629-6
▸ Aprobarbital LP14707-1
▸ Barbiturates | Meconium | Drug toxicology LP390630-4
▸ Barbiturate screen absent LP32964-6
▸ Barbiturate screen present LP32965-3
▸ Barbiturates | Saliva | Drug toxicology LP390631-2
▸ Barbiturates | Serum or Plasma | Drug toxicology LP390632-0
▸ Barbiturates present LP19560-9
▸ Barbiturates positive LP32966-1
▸ Barbiturates | Serum, Plasma or Blood | Drug toxicology LP390633-8
▸ Barbiturates | Stool | Drug toxicology LP390634-6
▸ Barbital LP16042-1
▸ Brallobarbital LP230256-2
▸ Barbiturates | Urine | Drug toxicology LP390635-3
▸ Barbiturates | Vitreous fluid | Drug toxicology LP390636-1
▸ Butabarbital LP16055-3
▸ Butalbital LP15046-3
▸ Barbiturates | XXX | Drug toxicology LP390637-9
▸ Dimethadione LP15540-5
▸ Hexobarbital LP18127-8
▸ Mephobarbital LP16186-6
▸ Metharbital LP18128-6
▸ Pentetrazol LP16240-1
▸ PENTobarbital LP16241-9
▸ PHENobarbital LP14729-5
▸ Secobarbital LP16277-3
▸ Thiamylal LP18126-0
▸ Thiopental LP16289-8
▸ Barbiturates.other LP71220-5
▸ Barbiturates tested for LP29001-2
▸ Barbiturates cutoff LP227740-0
▸ Barbiturates screen method LP32822-6
▸ Barbiturates confirm method LP32821-8
▸ Barbiturates/Creatinine LP285057-8
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.